Detrimental effects of mannose-binding lectin (MBL2) promoter genotype XA/XA on HIV-1 vertical transmission and AIDS progression

Journal of Infectious Diseases

Volumn 198, Issue 5, 2008, Pages 694-700

  Mangano, Andrea ^a,b   Rocco, C ^a   Marino, S M ^a   Mecikovsky, D ^a   Genre, F ^a   Aulicino, P ^a   Bologna, R ^a   Sen, L ^a,b  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^b Universidad Nacional de Río Cuarto Consejo Nacional de Investigaciones Científicas y Técnicas   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

MANNOSE BINDING LECTIN; MANNOSE BINDING LECTIN 2; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; GENE FREQUENCY; GENE FUNCTION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ALLELES; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE PROGRESSION; DISEASE TRANSMISSION, VERTICAL; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; MANNOSE-BINDING LECTIN; ODDS RATIO;

EID: 50949115283     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/590498     Document Type: Article

References (43)

1. Holmskov U, Malhotra R, Sim RB, Jensenius JC. Collectins: collagenous C-type lectins of the innate immune defense system. Immunol Today 1994; 15:67-74.
2. Petersen SV, Thiel S, Jensen L, Steffensen R, Jensenius JC. The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol 2001; 38:133-49.
3. Sastry K, Ezekowitz RA. Collectins: pattern recognition molecules involved in first line host defense [erratum: Curr Opin Immunol 1993; 5:566]. Curr Opin Immunol 1993; 5:59-66.
4. Turner MW. The role of mannose-binding lectin in health and disease. Mol Immunol 2003; 40:423-9.
5. Thiel S, Vorup-Jensen T, Stover CM, et al. A second serine protease associated with mannan-binding lectin that activates complement. Nature 1997; 386:506-10.
6. Sato T, Endo Y, Matsushita M, Fujita T. Molecular characterization of a novel serine protease involved in activation of the complement system by mannose-binding protein. Int Immunol 1994; 6:665-9.
7. Garred P, Larsen F, Seyfarth J, Fujita R, Madsen HO. Mannose-binding lectin and its genetic variants. Genes Immun 2006; 7:85-94.
8. Summerfield JA, Sumiya M, Levin M, Turner MW. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ 1997; 314:1229-32.
9. Garred P, Madsen HO, Hofmann B, Svejgaard A. Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency. Lancet 1995; 346:941-3.
10. Kilpatrick DC. Mannan-binding lectin: clinical significance and applications. Biochim Biophys Acta 2002; 1572:401-13.
11. Garred P, Voss A, Madsen HO, Junker P. Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun 2001; 2:442-50.
12. Lee YH, Witte T, Momot T, et al. The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus: 2 case-control studies and a meta-analysis. Arthritis Rheum 2005; 52:3966-74.
13. Jakab L, Laki J, Sallai K, et al. Association between early onset and organ manifestations of systemic lupus erythematosus (SLE) and a down-regulating promoter polymorphism in the MBL2 gene. Clin Immunol 2007; 125:230-6.
14. Saevarsdottir S, Vikingsdottir T, Vikingsson A, et al. Low mannose binding lectin predicts poor prognosis in patients with early rheumatoid arthritis: a prospective study. J Rheumatol 2001; 28:728-34.
15. Sumiya M, Super M, Tabona P, et al. Molecular basis of opsonic defect in immunodeficient children. Lancet 1991; 337:1569-70.
16. Lipscombe RJ, Sumiya M, Hill AV, et al. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene [erratum: HumMol Genet 1993; 2:342]. Hum Mol Genet 1992; 1:709-15.
17. Madsen HO, Garred P, Kurtzhals JAL, et al. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 1994; 40:37-44.
18. Madsen HO, Garred P, Thiel S, et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995; 155:3013-20.
19. Madsen HO, Satz ML, Hogh B, Svejgaard A, Garred P. Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol 1998; 161:3169-75.
20. Mead R, Jack D, Pembrey M, Tyfield L, Turner M. Mannose-binding lectin alleles in a prospectively recruited UK population. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Lancet 1997; 349:1669-70.
21. Lipscombe RJ, Beatty DW, Ganczakowski M, et al. Mutations in the human mannose-binding protein gene: frequencies in several population groups. Eur J Hum Genet 1996; 4:13-9.
22. Garred P, Larsen F, Madsen HO, Koch C. Mannose-binding lectin deficiency - revisited. Mol Immunol 2003; 40:73-84.
23. Crosdale DJ, Ollier WER, Thomson W, et al. Mannose binding lectin (MBL) genotype distributions with relation to serum levels in UK Caucasoids. Eur J Immunogenet 2000; 27:111-7.
24. Ezekowitz RA, Kuhlman M, Groopman JE, Byrn RA. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med 1989; 169:185-96.
25. Haurum JS, Thiel S, Jones IM, et al. Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins. AIDS 1993; 7:1307-13.
26. Saifuddin M, Hart ML, Gewurz H, Zhang Y, Spear GT. Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1. J Gen Virol 2000; 81:949-55.
27. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331:1173-80.
28. US Center for Disease Control and Prevention classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age. MMWR Morb Mortal Wkly Rep 1994; 43:1-10.
29. Garred P, Madsen HO, Balslev U, et al. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet 1997; 349:236-40.
30. Garred P, Richter C, Andersen AB, et al. Mannan-binding lectin in the sub-Saharan HIV and tuberculosis epidemics. Scand J Immunol 1997; 46:204-8.
31. Malik S, Arias M, Di Flumeri C, Garcia LF, Schurr E. Absence of association between mannose-binding lectin gene polymorphisms and HIV-1 infection in a Colombian population. Immunogenetics 2003; 55:49-52.
32. Pastinen T, Liitsola K, Niini P, Salminen M, Syvänen AC. Contribution of the CCR5 and MBL genes to susceptibility to HIV type 1 infection in the Finnish population. AIDS Res Hum Retroviruses 1998; 14:695-8.
33. Amoroso A, Berrino M, Boniotto M, et al. Polymorphism at codon 54 of mannose-binding protein gene influences AIDS progression but not HIV infection in exposed children. AIDS 1999; 13:863-4.
34. McBride MO, Fischer PB, Sumiya M, et al. Mannose-binding protein in HIV-seropositive patients does not contribute to disease progression or bacterial infections. Int J STD AIDS 1998; 9:683-8.
35. Maas J, de Roda Husman A-M, Brouwer M, et al. Presence of the variant mannose-binding lectin alleles associated with slower progression to AIDS. AIDS 1998; 12:2275-80.
36. Hundt M, Heiken H, Schmidt RE. Low mannose-binding lectin serum concentrations in HIV long-term nonprogressors? AIDS Res Hum Retroviruses 2000; 16:1927.
37. Boniotto M, Braida L, Pirulli D, et al. MBL2 polymorphisms are involved in HIV-1 infection in Brazilian perinatally infected children. AIDS 2003; 17:779-90.
38. Boniotto M, Crovella S, Pirulli D, et al. Polymorphisms in the MBL2 promoter correlated with risk of HIV-1 vertical transmission and AIDS progression. Genes Immun 2000; 1:346-8.
39. Senaldi G, Davies ET, Mahalingam M, et al. Circulating levels of mannose binding protein in human immunodeficiency virus infection. J Infect 1995; 31:145-8.
40. Heggelund L, Mollnes TE, Ueland T, et al. Mannose-binding lectin in HIV infection: relation to disease progression and highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2003; 32:354-61.
41. Nielsen SL, Andersen PL, Koch C, Jensenius JC, Thiel S. The level of the serum opsonin, mannan-binding protein in HIV-1 antibody-positive patients. Clin Exp Immunol 1995; 100:219-22.
42. Boniotto M, Radillo O, Braida L, et al. Detection of MBL-2 gene expression in intestinal biopsies of celiac patients by in situ reverse transcription polymerase chain reaction. Eur J Histochem 2003; 47:177-80.
43. Seyfarth J, Garred P, Madsen HO. Extra-hepatic transcription of the human mannose-binding lectin gene (mbl2) and the MBL-associated serine protease 1-3 genes. Mol Immunol 2006; 43:962-71.